Financials
Q3 Trading Update | Apr. 10, 2025 |
Half-year Report | Mar. 18, 2025 |
Trading Update | Jan. 27, 2025 |
Audited Full Year Fiscal 2024 Results | Nov. 21, 2024 |
Financial Results for Q1 of Fiscal Year 2025 | Nov. 20, 2024 |
Audited US GAAP financial results | Oct. 01, 2024 |
Renalytix Reports Financial Results for Q3 FY2024 | May. 15, 2024 |
Proxies
Publication of Annual Report and Notice of AGM | Nov. 26, 2024 |
Result of AGM | Dec. 15, 2023 |
Publication of Annual Report 2023 & Notice of AGM | Nov. 17, 2023 |
Result of AGM | Dec. 19, 2022 |
Result of AGM | Dec. 17, 2021 |
Ownership Update
Holding(s) in Company | Jun. 27, 2025 |
Holding(s) in Company | Jun. 26, 2025 |
Holding(s) in Company | May. 30, 2025 |
Holding(s) in Company | May. 29, 2025 |
Holding(s) in Company | May. 27, 2025 |
Holding(s) in Company | May. 16, 2025 |
Holding(s) in Company | Apr. 29, 2025 |
Announcements
kidneyintelX.dkd data presented at ERA Congress | Jun. 17, 2025 |
Growing collaboration with NYKHM | Jun. 03, 2025 |
First use of KidneyIntelX in new CKD therapy trial | May. 20, 2025 |
Late Breaking KidneyIntelX data show care impact | Apr. 16, 2025 |
Notice of Interim Results & Investor Presentation | Mar. 12, 2025 |
Publication in journal (JASN) for kidneyIntelX.dkd | Feb. 06, 2025 |
Foreign Private Issuer re-qualification | Jan. 17, 2025 |